Association of asymmetric dimethylarginine levels with treadmill-stress-test-derived prognosticators

Clinical Biochemistry

Volumn 47, Issue 7-8, 2014, Pages 593-598

  Deftereos, Spyridon ^a,f   Bouras, Georgios ^a   Tsounis, Dimitrios ^a   Papadimitriou, Charalampos ^a   Hatzis, George ^b   Raisakis, Konstantinos ^a   Panagopoulou, Vasiliki ^a,c   Kaoukis, Andreas ^a   Ioannidis, Antonis ^e   Deftereos, Gerasimos ^a   Kossyvakis, Charalampos ^a,c   Manolis, Antonis S ^b   Alexopoulos, Dimitrios ^d   Stefanadis, Christodoulos ^b   Cleman, Michael W ^f   Giannopoulos, Georgios ^a,c,f  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Hellenic Center for Disease Control and Prevention   (Greece)

^d UNIVERSITY OF PATRAS   (Greece)

^e HELLENIC OPEN UNIVERSITY   (Greece)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADMA; Biomarker; Coronary artery disease; Prognosis; Stress test

Indexed keywords

N(G),N(G) DIMETHYLARGININE; ARGININE; BIOLOGICAL MARKER; N,N-DIMETHYLARGININE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DUKE TREADMILL SCORE; DYSLIPIDEMIA; EXERCISE; EXERCISE TEST; FAMILY HISTORY; FEMALE; GENDER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC EQUIVALENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM; SMOKING; SYMPTOM; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE STRESS TEST; AGED; ANALOGS AND DERIVATIVES; BLOOD; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR;

AGED; ARGININE; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 84900345822     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.01.031     Document Type: Article

References (44)

1. Valkonen V.P., Päivä H., Salonen J.T., Lakka TA, Lehtimäki T, Laakso J, et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 2001, 358:2127-2128.
2. Lu T.-M., Ding Y.-A., Charng M.-J., Lin S.-J. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease. Clin Cardiol 2003, 26:458-464.
3. Schnabel R., Blankenberg S., Lubos E., Lackner KJ, Rupprecht HJ, Espinola-Klein C, et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 2005, 97:e53-e59.
4. Schulze F., Lenzen H., Hanefeld C., Bartling A, Osterziel KJ, Goudeva L, et al. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J 2006, 152:493. [e1-8.].
5. Gibbons R.J., Balady G.J., Bricker J.T., Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002, 106:1883-1892.
6. Fihn S.D., Gardin J.M., Abrams J., Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012, 60:e44-e164.
7. Lipinski M., Do D., Froelicher V., Osterberg L, Franklin B, West J, et al. Comparison of exercise test scores and physician estimation in determining disease probability. Arch Intern Med 2001, 161:2239-2244.
8. Kohli P., Gulati M. Exercise stress testing in women: going back to the basics. Circulation 2010, 122:2570-2580.
9. Khattar R.S., Nair S.B., Hamid T., Chacko S, Mamas M, Turkie W, et al. Prognostic value of demographic factors, pre-test probability scoring, exercise test diagnosis, and inability to exercise in patients with recent onset suspected cardiac chest pain. Eur J Prev Cardiol 2012, 19:419-427.
10. Diamond G.A., Forrester J.S. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979, 300:1350-1358.
11. Mancia G., Fagard R., Narkiewicz K., Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013, 34:2159-2219.
12. Ryden L., Grant P.J., Anker S.D., Berne C, Cosentino F, Danchin N, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on Diabetes, Pre-diabetes, and Cardiovascular Diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). European heart journal 2013, 34:3035-3087.
13. Perk J., De Backer G., Gohlke H., Graham I, Reiner Z, Verschuren M, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). European heart journal 2012, 33:1635-1701.
14. Bruce R.A. Methods of exercise testing. Step test, bicycle, treadmill, isometrics. Am J Cardiol 1974, 33:715-720.
15. Wilson M.F., Sung B.H., Pincomb G.A., Lovallo W.R. Exaggerated pressure response to exercise in men at risk for systemic hypertension. Am J Cardiol 1990, 66:731-736.
16. Lauer M.S., Francis G.S., Okin P.M., Pashkow F.J., Snader C.E., Marwick T.H. Impaired chronotropic response to exercise stress testing as a predictor of mortality. Jama 1999, 281:524-529.
17. Mark D.B., Shaw L., Harrell F.E., Hlatky MA, Lee KL, Bengtson JR, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991, 325:849-853.
18. Druhan L.J., Forbes S.P., Pope A.J., Chen C.-A., Zweier J.L., Cardounel A.J. Regulation of eNOS-derived superoxide by endogenous methylarginines. Biochemistry 2008, 47:7256-7263.
19. El-Mesallamy H.O., Abdel Hamid S.G., Gad M.Z. Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by l-arginine intake. Kidney Blood Press Res 2008, 31:189-195.
20. Antoniades C., Tousoulis D., Marinou K., Vasiliadou C, Tentolouris C, Bouras G, et al. Asymmetrical dimethylarginine regulates endothelial function in methionine-induced but not in chronic homocystinemia in humans: effect of oxidative stress and proinflammatory cytokines. Am J Clin Nutr 2006, 84:781-788.
21. Blackwell S. The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine. Ann Clin Biochem 2010, 47:17-28.
22. Bouras G., Deftereos S., Tousoulis D., Giannopoulos G, Chatzis G, Tsounis D, et al. Asymmetric dimethylarginine (ADMA): a promising biomarker for cardiovascular disease?. Curr Top Med Chem 2013, 13:180-200.
23. Hori T., Matsubara T., Ishibashi T., Ozaki K, Tsuchida K, Mezaki T, et al. Significance of asymmetric dimethylarginine (ADMA) concentrations during coronary circulation in patients with vasospastic angina. Circ J 2003, 67:305-311.
24. Richter B., Niessner A., Penka M., Grdić M, Steiner S, Strasser B, et al. Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events. Thromb Haemost 2005, 94:1306-1311.
25. Selcuk M.T., Selcuk H., Temizhan A., Maden O, Ulupinar H, Baysal E, et al. Asymmetric dimethylarginine plasma concentrations and l-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow. Coron Artery Dis 2007, 18:545-551.
26. Sen N., Tavil Y., Erdamar H., Yazici HU, Cakir E, Akgül EO, et al. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X. Anadolu Kardiyol Derg 2009, 9:371-379.
27. Atzeni F., Sarzi-Puttini P., Sitia S., Tomasoni L, Gianturco L, Battellino M, et al. Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritis. J Rheumatol 2011, 38:1661-1664.
28. Cao Y., Yang K., Zhang Z., Ouyang M., Xiao L. Correlation between plasma asymmetric dimethylarginine and different types of coronary heart disease. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2010, 35:301-306.
29. Gürel E., Tigen K., Karaahmet T., Geçmen C., Mutlu B., Başaran Y. Predictive value of plasma asymmetric dimethylarginine, homocysteine, and high-sensitive CRP levels in occult coronary artery disease: a multidetector-row computed tomography study. Herz 2013, 10.1007/s00059-013-4022-9.
30. Hsu C.P., Lin S.J., Chung M.Y., Lu T.M. Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure. Atherosclerosis 2012, 225:504-510.
31. Løland K.H., Bleie O., Borgeraas H., Strand E, Ueland PM, Svardal A, et al. The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine. PLoS One 2013, 8:e64774.
32. Bourque J.M., Holland B.H., Watson D.D., Beller G.A. Achieving an exercise workload of > or =10 metabolic equivalents predicts a very low risk of inducible ischemia: does myocardial perfusion imaging have a role?. J Am Coll Cardiol 2009, 54:538-545.
33. Shaw L.J., Peterson E.D., Shaw L.K., Kesler KL, Delong ER, Harrell FE, et al. Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circulation 1998, 98:1622-1630.
34. Singh J.P., Larson M.G., Manolio T.A., O'donnell CJ, Lauer M, Evans JC, et al. Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham Heart Study. Circulation 1999, 99:1831-1836.
35. Kayrak M., Bacaksiz A., Vatankulu M.A., Ayhan SS, Kaya Z, Ari H, et al. Exaggerated blood pressure response to exercise-a new portent of masked hypertension. Clin Exp Hypertens 2010, 32:560-568.
36. Kallistratos M.S., Poulimenos L.E., Pavlidis A.N., Dritsas A, Laoutaris ID, Manolis AJ, et al. Prognostic significance of blood pressure response to exercise in patients with systolic heart failure. Heart Vessels 2012, 27:46-52.
37. Cho M.S., Jang S.-J., Lee C.H., Park C.-H. Association of early systolic blood pressure response to exercise with future cardiovascular events in patients with uncomplicated mild-to-moderate hypertension. Hypertens Res 2012, 35:922-927.
38. Kurl S., Laukkanen J.A., Rauramaa R., Lakka T.A., Sivenius J., Salonen J.T. Systolic blood pressure response to exercise stress test and risk of stroke. Stroke 2001, 32:2036-2041.
39. Chang H.J., Chung J.H., Choi B.J., et al. Endothelial dysfunction and alteration of nitric oxide/cyclic GMP pathway in patients with exercise-induced hypertension. Yonsei Med J 2003, 44:1014-1020.
40. Stewart K.J., Sung J., Silber H.A., Fleg JL, Kelemen MD, Turner KL, et al. Exaggerated exercise blood pressure is related to impaired endothelial vasodilator function. Am J Hypertens 2004, 17:314-320.
41. Kayrak M., Bacaksiz A., Vatankulu M.A., Ayhan SS, Taner A, Unlü A, et al. Association between exaggerated blood pressure response to exercise and serum asymmetric dimethylarginine levels. Circ J 2010, 74:1135-1141.
42. Chen J.-W., Hsu N.-W., Wu T.-C., Lin S.-J., Chang M.-S. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 2002, 90:974-982.
43. Tomiyama H., Yamada J., Koji Y., Shiina K., Yoshida M., Yamashina A. Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels. Am J Hypertens 2007, 20:1305-1311.
44. Riccioni G., Speranza L., Scotti L., Bucciarelli V, Di Ilio E, Dorazio N, et al. The effect of pharmacological treatment on ADMA in patients with heart failure. Front Biosci 2011, 3:1310-1314. [Elite Ed].